























![]()
Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Positive Interim Results from Phase 2 Setmelanotide Trial in Prader-Willi Syndrome June 13, 2026 9:00 AM EDT
Company Participants
David Connolly - Head of Investor Relations & Corporate Communications
David Meeker - Chairman, President & CEO
Conference Call Participants
Jennifer L Miller
Tazeen Ahmad - BofA Securities, Research Division
Philip Nadeau - TD Cowen, Research Division
Derek Archila - Wells Fargo Securities, LLC, Research Division
Seamus Fernandez - Guggenheim Securities, LLC, Research Division
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division
Rohit Bhasin - Morgan Stanley, Research Division
Jonathan Wolleben - Citizens JMP Securities, LLC, Research Division
Paul Matteis - Stifel, Nicolaus & Company, Incorporated, Research Division
Joseph Stringer - Needham & Company, LLC, Research Division
Lisa Walter - RBC Capital Markets, Research Division
Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division
Leland Gershell - Oppenheimer & Co. Inc., Research Division
Presentation
Operator
Good day, everyone, and thank you for standing by. Welcome to Rhythm Pharmaceuticals Results from Phase II Prader-Willi Syndrome trial. [Operator Instructions] Please be advised that today's conference is being recorded. Now it's my pleasure to hand the conference to David Connolly with Investor Relations at Rhythm Pharmaceuticals. Please proceed.
David Connolly
Head of Investor Relations & Corporate Communications
Thank you, [Carmen]. I'm Dave Connolly here at Rhythm Pharmaceuticals. This morning, we issued a press release announcing positive interim data from our Phase II trial of setmelanotide in patients with Prader-Willi syndrome. That press release is available on our website. Also, our slides for this call can be accessed and controlled by going to the Investors section of our website at ir.rhythmtx.com. On the call today are David Meeker, our Chairman, Chief Executive Officer and President of Rhythm Pharmaceuticals; and Dr. Jennifer Miller, Pediatric Endocrinologist at the University of Florida.
On Slide 3, I'll remind you that this call contains remarks
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。